SpyGlass Pharma, Inc. (SGP) earnings date
Mar 25, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 35% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 44 days, typically, give or take 22 (last 4 releases) |
Last 4 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | before open | 43 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | after close | 37 | 8-K |
| Q1 FY2026 | Thu, May 14, 2026 | after close | 44 | 8-K |
| Q4 FY2025 | Thu, Mar 26, 2026 | after close | 85 | 8-K |
What they guided beta
| Q3 FY2026 | "Enrollment remains on track in the registrational Phase 3 trials of the BIM-IOL System, with completion expected in 2027." exhibit |
| Q3 FY2026 | "Cash, cash equivalents and short-term investments of $215.8 million on September 30, 2026, are expected to fund planned operations through 2028." exhibit |
| Q3 FY2026 | "SpyGlass Pharma anticipates providing preliminary safety and IOP-lowering efficacy data for the BIM-DRS FIH trial in 2027." exhibit |
| Q2 FY2026 | "Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027." exhibit |
| Q2 FY2026 | "Bimatoprost-Drug Ring System (BIM-DRS) first-in-human trial is on track to start in the second half of 2026." exhibit |
| Q2 FY2026 | "Cash, cash equivalents and short-term investments of $234.2 million on June 30, 2026, are expected to fund planned operations through 2028." exhibit |
| Q2 FY2026 | "BIM-DRS: Initiation of the FIH trial expected in the second half of 2026." exhibit |
| Q2 FY2026 | "BIM-IOL System: Four-year efficacy and safety follow-up expected in fourth quarter of 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/SGP
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/SGP
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/SGP/"><img src="https://veritasdata.dev/embed/SGP.svg" alt="SGP earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/SGP/)
Script
<script async src="https://veritasdata.dev/embed/SGP.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/SGP"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.